Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

ABSTRACT:

SUBMITTER: Frigault MJ 

PROVIDER: S-EPMC7332891 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature